geranyl-O-acetylhydroquinone

structure in first source

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Experimental Melanoma 12/30/2003 - "Farnesyl-O-acetylhydroquinone and geranyl-O-acetylhydroquinone suppress the proliferation of murine B16 melanoma cells, human prostate and colon adenocarcinoma cells, human lung carcinoma cells, and human leukemia cells."
2.	Leukemia 12/30/2003 - "Farnesyl-O-acetylhydroquinone and geranyl-O-acetylhydroquinone suppress the proliferation of murine B16 melanoma cells, human prostate and colon adenocarcinoma cells, human lung carcinoma cells, and human leukemia cells."
3.	Colonic Neoplasms (Colon Cancer) 12/30/2003 - "Farnesyl-O-acetylhydroquinone and geranyl-O-acetylhydroquinone suppress the proliferation of murine B16 melanoma cells, human prostate and colon adenocarcinoma cells, human lung carcinoma cells, and human leukemia cells."
4.	Carcinoma (Carcinomatosis) 12/30/2003 - "Farnesyl-O-acetylhydroquinone and geranyl-O-acetylhydroquinone suppress the proliferation of murine B16 melanoma cells, human prostate and colon adenocarcinoma cells, human lung carcinoma cells, and human leukemia cells."

1.	farnesyl-O-acetylhydroquinone